Pfizer, Sandoz Patent Spat Over Caduet Heads To Del.

Law360, New York (February 10, 2010, 1:48 PM EST) -- Pfizer Inc. has won its bid to transfer to Delaware federal court a patent infringement case over Sandoz Inc.'s abbreviated new drug application to manufacture a generic version of blood pressure and cholesterol reducer Caduet.

Judge Christine Arguello of the U.S. District Court for the District of Colorado on Monday granted Pfizer's motion to transfer its Colorado suit against Sandoz to the District of Delaware, where a similar suit between the two companies is pending.

Pfizer brought essentially identical actions against Sandoz in Delaware and Colorado...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.